Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.65
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
205,648
Open
27.65
Bid (Size)
27.46 (100)
Ask (Size)
27.47 (100)
Prev. Close
27.65
Today's Range
27.65 - 27.65
52wk Range
20.91 - 27.94
Shares Outstanding
5,606,688,356
Dividend Yield
6.22%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
↗
March 01, 2026
Don't follow general market sentiment when it comes to these two stocks.
Via
The Motley Fool
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
↗
March 01, 2026
Eli Lilly is making headlines in the pharmaceutical sector, but it's a very expensive stock.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+9.8%
+9.8%
1 Month
+4.6%
+4.6%
3 Month
+9.4%
+9.4%
6 Month
+10.7%
+10.7%
1 Year
+5.3%
+5.3%
More News
Read More
Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole
↗
February 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
Big Tech’s Heavy Lifting: S&P 500 Q4 Earnings Surpass 8% Growth Amid AI Capex Anxiety
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Electric Vehicles
The Implementation Pivot: How Accenture Defied the ‘SaaS-pocalypse’ with a Massive AI Rebound
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Industrial Renaissance: Sector Surges 27% in Q4 2025 as Healthcare and Consumer Discretionary Lag
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
February 27, 2026
Via
Barchart.com
Topics
Stocks
The Great Pivot: Inside Novavax’s 2026 Turnaround and the Road to Combination Vaccines
February 27, 2026
Via
Finterra
Topics
Economy
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
February 27, 2026
From
Pfizer Inc.
Via
Business Wire
Amneal (AMRX) Q4 2025 Earnings Call Transcript
↗
February 27, 2026
Via
The Motley Fool
Topics
Earnings
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver?
↗
February 27, 2026
Via
Stocktwits
Topics
Earnings
2 Reasons to Like ZTS (and 1 Not So Much)
February 26, 2026
Via
StockStory
Topics
Stocks
OPKO Health (OPK) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Via
The Motley Fool
Topics
Earnings
Love Dividends? 1 Stock to Buy Now With a Yield Over 6%.
February 26, 2026
Via
Barchart.com
Topics
Artificial Intelligence
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
February 26, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
February 26, 2026
Via
Finterra
Topics
Economy
This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
February 26, 2026
Via
Benzinga
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025
February 26, 2026
Via
StockStory
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash
↗
February 26, 2026
Via
Stocktwits
Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know.
↗
February 25, 2026
Via
The Motley Fool
Pfizer's Braftovi Regimen Wins Complete FDA Nod For Colorectal Cancer Treatment
↗
February 25, 2026
Via
Benzinga
Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment
↗
February 25, 2026
Via
Benzinga
Pfizer Stock: Is PFE Underperforming the Healthcare Sector?
February 25, 2026
Via
Barchart.com
Topics
ETFs
Intellectual Property
World Trade
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.65
When was Pfizer last traded?
The last trade of Pfizer was at 02/27/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 155.02B
How many shares of Pfizer are outstanding?
Pfizer has 155B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.